Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Focal Segmental Glomerulosclerosis”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Testing effectiveness (Phase 2)Looking for participantsNCT06664814
What this trial is testing

An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis
National Human Genome Research Institute (NHGRI) 30
Testing effectiveness (Phase 2)Study completedNCT02000440
What this trial is testing

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Glomerulosclerosis, Focal Segmental
GlaxoSmithKline 17
Not applicableLooking for participantsNCT04924712
What this trial is testing

INS, B Cells and Microbiota

Who this might be right for
MicrobiotaB-lymphocytesGlomerulosclerosis+1 more
Nantes University Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Testing effectiveness (Phase 2)Study completedNCT02921789
What this trial is testing

Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationPrimary Focal Segmental Glomerulosclerosis (FSGS)
Astellas Pharma Global Development, Inc. 67
Not applicableStudy completedNCT00255398
What this trial is testing

Kidney Disease Biomarkers

Who this might be right for
Kidney DiseaseGlomerular DiseaseIdiopathic Nephrotic Syndrome+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Early research (Phase 1)Study completedNCT00193648
What this trial is testing

Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Glomerulosclerosis
Northwell Health 21
Early research (Phase 1)Ended earlyNCT00816478
What this trial is testing

Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor

Who this might be right for
Focal Segmental Glomerulosclerosis
Northwell Health 15
Early research (Phase 1)UnknownNCT02382874
What this trial is testing

Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)

Who this might be right for
Focal Segmental Glomerulosclerosis
Royan Institute 5
Testing effectiveness (Phase 2)Study completedNCT01665391
What this trial is testing

Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Primary Focal Segmental Glomerulosclerosis
Genzyme, a Sanofi Company 36
Testing effectiveness (Phase 2)WithdrawnNCT05599815
What this trial is testing

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Aldeyra Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT03649152
What this trial is testing

Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan

Who this might be right for
Focal Segmental Glomerulosclerosis
Dimerix Bioscience Pty Ltd 8
Post-approval studies (Phase 4)Study completedNCT01155141
What this trial is testing

Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH

Who this might be right for
Kidney Diseases
Stanford University 15
Not applicableLooking for participantsNCT03949972
What this trial is testing

The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Who this might be right for
Glomerulosclerosis, Focal SegmentalMinimal Change DiseaseIdiopathic Nephrotic Syndrome
Prof. Dr. Paul Brinkkoetter 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07220083
What this trial is testing

Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis
Boehringer Ingelheim 286
Not applicableWithdrawnNCT00302536
What this trial is testing

Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Glomerulosclerosis
Nanjing University School of Medicine
Large-scale testing (Phase 3)UnknownNCT03298698
What this trial is testing

Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic SyndromeMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Radboud University Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00814255
What this trial is testing

Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial

Who this might be right for
Focal Segmental Glomerulosclerosis
NYU Langone Health 32
Testing effectiveness (Phase 2)Ended earlyNCT05441826
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Minimal Change DiseaseFocal Segmental Glomerulosclerosis
Tenet Medicines 1
Not applicableLooking for participantsNCT02235857
What this trial is testing

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

Who this might be right for
Focal Segmental Glomerulosclerosis
Kaneka Medical America LLC 35
Load More Results